Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/112041
DC FieldValue
dc.titleRecombinant human tumor necrosis factor-β entrapped in liposomes formed by a modification of the dehydration-rehydration method retains potent cytotoxic activity on L929 cells in vitro
dc.contributor.authorTan, L.
dc.contributor.authorGoh, C.R.
dc.contributor.authorPorter, A.G.
dc.date.accessioned2014-11-28T02:52:31Z
dc.date.available2014-11-28T02:52:31Z
dc.date.issued1992
dc.identifier.citationTan, L.,Goh, C.R.,Porter, A.G. (1992). Recombinant human tumor necrosis factor-β entrapped in liposomes formed by a modification of the dehydration-rehydration method retains potent cytotoxic activity on L929 cells in vitro. Japanese Journal of Pharmacology 59 (2) : 235-238. ScholarBank@NUS Repository.
dc.identifier.issn00215198
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/112041
dc.description.abstractRecombinant human tumor necrosis factor-β (rhTNF-β) may be encapsulated with high efficiency in phosphatidylcholine and distearoylphosphatidylcholine liposomes, with entrapment values of 93.4% and 92.3%, respectively, by first entrapping the substance in multilamellar vesicles using a high solute-to-phospholipid ratio followed by freeze-drying and then rehydration. The entrapped cytokine retains potent cytotoxic activity on L929 cells in vitro, causing 100% cytotoxicity, equal to that of free rhTNF-β at a concentration of about 5 X 10-8g/ml.
dc.sourceScopus
dc.subjectL929 cells
dc.subjectLiposomes
dc.subjectTumor necrosis factor-β
dc.typeArticle
dc.contributor.departmentINSTITUTE OF MOLECULAR & CELL BIOLOGY
dc.description.sourcetitleJapanese Journal of Pharmacology
dc.description.volume59
dc.description.issue2
dc.description.page235-238
dc.description.codenJJPAA
dc.identifier.isiutNOT_IN_WOS
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.